Rabies post exposure prophylaxis, or PEP, consists of a rabies vaccine series and human rabies immune globulin (HRIG).

Kedrion Biopharma’s human rabies immune globulin, Kedrab, was FDA approved in 2017. And now for the first time, the safety of HRIG (Kedrab) was studied in children.

Joining me today to discuss rabies, PEP and the pediatric trial is James Linakis, MD, PhD. Dr. Linakis is Professor of Emergency Medicine and Pediatrics at Brown Medical School and Associate Director of Pediatric Emergency Medicine at Rhode Island Hospital’s Hasbro Children’s Hospital.

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

 


Related:

Rabies and Travel Health with Dr. Jonas Nilsen

Rabies: Signs and symptoms, exposure, transmission and diagnostics

Rabies in the US: Geography, wildlife, exposure and prevention

Zoonotic diseases in the US: Rabies, Lyme disease among eight of most concern

Rabies: The fatal Virginia case and some important lessons

Rabies: What should you do if you’re exposed?

Rabies death reported in Utah, First since 1944

Rabies: History, myths and diagnosis on Outbreak News This Week

James Linakis, MD, PhD